References
- Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2013; 99(1): 63.23095139
- Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010; 93(4): 1234-1243.10.1016/j.fertnstert.2009.01.16619338986
- Ford HB, Schust DJ. Recurrent pregnancy loss: Etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009; 2(2): 76-83.19609401
- Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014; 7(3): 159-169.10.4103/0974-1208.14247525395740
- Christiansen OB. Reproductive immunology. Mol Immunol. 2013; 55(1): 8-15.10.1016/j.molimm.2012.08.02523062611
- Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatal. 2016; 33(14): 1337-1356.10.1055/s-0036-1582397
- Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann NY Acad Sci. 2011; 1221(1): 80-87.10.1111/j.1749-6632.2010.05938.x
- Doni A, Garlanda C, Mantovani A. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin Immunol. 2016; 28(6): 570-577.10.1016/j.smim.2016.10.01227881292
- Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010; 28: 157-183.1996856110.1146/annurev-immunol-030409-101305
- Garlanda C, Maina V, Cotena A, Moalli F. The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. J Reprod Immunol. 2009; 83(1-2): 128-133.10.1016/j.jri.2009.05.00619900712
- Casula M, Montecucco F, Bonaventura A, Liberale L, Vecchié A, Dallegri F, et al. Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases. Vascul Pharmacol. 2017; 99: 1-12.2905108810.1016/j.vph.2017.10.003
- Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation. 2011; 34(5): 448-451.10.1007/s10753-010-9252-x20852923
- Lekva T, Michelsen AE, Bollerslev J, Norwitz ER, Aukrust P, Henriksen T, et al. Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: A 5-year follow-up study. Cardiovasc Diabetol. 2016; 15:23.10.1186/s12933-016-0345-126842615
- Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006; 108(1): 148-155.10.1097/01.AOG.0000224607.46622.bc
- Willeke F, Assad A, Findeisen P, Schromm E, Grobholz R, von Gerstenbergk B, et al. Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma. Eur J Cancer. 2006; 42(15): 2639-2646.1695948510.1016/j.ejca.2006.05.035
- Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, et al. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol. 2014; 165(3): 165-178.10.1159/000368778
- Giacomini A, Ghedini GC, Presta M, Ronca, R. Long pentraxin 3: A novel multifaceted player in cancer. Biochim Biophys Acta. 2018; 1869(1): 53-63.
- Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli A, Calabrese S, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta. 2012; 33(12): 1039-1044.10.1016/j.placenta.2012.09.00923062219
- Zhou P, Luo X, Qi HB,Zong WJ, Zhang H, Liu DD, et al. The expression of pentraxin 3 and tumor necrosis factor-α is increased in preeclamptic placentai tissue and maternal serum. Inflamm Res. 2012; 61(9): 10051012.
- Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides KH. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009; 29(10): 934-938.1956560910.1002/pd.2311
- Baschat AA, Kasdaglis TL, Aberdeen GW, Turan OM, Kopelman JL, Atlas R, et al. Serum pentraxin-3 levels at 11 to 14 weeks' gestation: Association with maternal and placentai characteristics. Am J Obstet Gynecol. 2009; 201(3): 298.el-298.e6.19631929
- Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli A, Garlanda C, et al. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand. 2009; 88(7): 846-849.1954420210.1080/00016340902971441
- Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007; 77(3): 425-432.10.1095/biolreprod.107.06241417538075
- Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006; 147(12): 5662-5675.10.1210/en.2006-0916
- Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, et al. Decidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulators. Biol Reprod. 2007; 76(1): 102-117.10.1095/biolreprod.106.05479117021345
- Cruciani L, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Mazaki-Tovi S, et al. Pentraxin 3 in maternal circulation: An association with preterm labor and preterm PROM, but not with intra-amniotic infection/innammation. J Matern Fetal Neonatal Med. 2010; 23(10): 1097-1105.10.3109/14767050903551509
- Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P, Mantovani A, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. Br J Obstet Gynaecol. 2007; 114(2): 143-147.10.1111/j.1471-0528.2006.01225.x
- Jo YS, Cheon JY, Ahn JW, Kim Y, Lee GSR. Pentraxin 3 and lipid profile status in pregnancy. J Obstet Gynaecol. 2017; 37(3): 727-730.2842185310.1080/01443615.2017.1291596
- Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH, Abdelgwad MH. First trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2012; 165(1): 37-41.2288949210.1016/j.ejogrb.2012.07.016
- Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et al. An alternative role of Clq in cell migration and tissue remodeling: Contribution to trophoblast invasion and placentai development. J Immunol. 2010; 185(7): 4420-4429.10.4049/jimmunol.0903215
- Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, et al. Emerging and novel functions of complement protein Clq. Front Immunol. 2015; 6: 317.
- Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 58(4): 716-724.10.1161/HYPERTENSIONAHA.111.17591921859968